UnitedHealth just handed in a quarter that would be unremarkable at any other company. At this one, it's a recovery story.
The country's largest health insurer reported Q1 earnings Tuesday morning. Adjusted earnings of $7.23 per share beat the $6.57 Wall Street expected. Revenue ran $111.7 billion, up from $109.6 billion last year. The stock jumped nearly 8%.
Last year was the worst in UnitedHealth's history. A CEO assassination. A DOJ probe into Medicare Advantage billing. A cyberattack on its Change Healthcare arm. Medical costs running far ahead of what the company had priced.
That pressure showed up in one number: the medical care ratio, which tracks how much of every premium dollar goes out the door as member care. It hit 84.8% last year. Wall Street watched the line like an ICU monitor.
This quarter it dropped to 83.9%. That's the first clean move lower in five quarters. It means pricing is catching up to costs again.
UnitedHealth lifted its full-year adjusted earnings outlook to more than $18.25 per share, up from "more than $17.75." A 50-cent bump sounds small. For a company that spent 2025 cutting guidance three times, it's a full reversal.
Optum Health is still under pressure. Value-based care margins are tighter than the company expected a year ago. But Medicare Advantage membership is holding, and commercial insurance growth is running ahead of plan.
Last year broke UnitedHealth in a way nothing else ever had. CEO Brian Thompson was killed. The DOJ opened a probe into Medicare Advantage billing. A cyberattack on the Change Healthcare arm dragged operations for months. Medical costs ran ahead of price three quarters in a row.
The company cut guidance three separate times in 2025, which is the kind of thing that doesn't happen at a name this size unless the model is genuinely broken.
This quarter is the first clean print since any of that started. It's why the medical care ratio dropping below 84% matters so much. It tells investors the pricing catch-up is real, not a one-time adjustment hiding something worse in the next print.
The other signal is the full-year raise. A $0.50 bump on the EPS outlook after three cuts last year is the kind of move management only makes when internal data looks clean for at least two quarters out.
Think of it like a patient walking out of the ICU. The vitals are stable, but the chart still shows what happened. UnitedHealth's clean quarter is the first vital sign that came in normal.
Health insurance stocks took a beating through 2025. Humana, Elevance, and CVS all cut forecasts. UnitedHealth's print is the first real read on whether the whole sector is turning.
Humana reports next month. That tells us whether this was a UnitedHealth story or a sector story.
The Street just priced it as the latter.
